Edition:
United Kingdom

Insider Trading: Eisai Co Ltd (4523.T)

4523.T on Tokyo Stock Exchange

6,376JPY
19 Apr 2019
Change (% chg)

-- (--)
Prev Close
¥6,376
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,090,022
52-wk High
¥11,490
52-wk Low
¥6,040

All Insider Trades

Institutional Holders

% Shares Owned: 40.68%
# of Holders: 299
Total Shares Held: 120,649,488
3 Mo. Net Change: -1,519,685
# New Positions: 6
# Closed Positions: 7
# Increased Positions: 64
# Reduced Positions: 67
# Net Buyers: -3

Officers & Directors

Name Age Since Current Position

Yasuhiko Kato

71 2018 Chairman of the Board of Directors, Independent Director

Haruo Naito

70 2014 Chief Executive Officer, Representative Executive Officer, Director

Ryohei Yanagi

56 2015 Managing Executive Officer, Chief Financial Officer, Chief IR Officer

Hideki Hayashi

60 2016 Representative Executive Officer, Chief Information Officer

Junichi Asatani

57 2014 Executive Officer, Chief Compliance Officer

Kenta Takahashi

58 2016 Managing Executive Officer, General Counsel, President of Subsidiary

Ivan Cheung

41 2016 Managing Executive Officer, President of Neurology Business Group, President of America Region, Chairman & Chief Executive Officer of Subsidiary

Edward Geary

55 2013 Managing Executive Officer, Chief Medical Officer, Chief Director of Corporate Medical Affairs

Gary Hendler

51 2016 Managing Executive Officer, President of EMEA Region, Chief Commercial Officer of Oncology Business Group, President & Chief Executive Officer of Subsidiary

Terushige Iike

54 2016 Managing Executive Officer, President of Oncology Business Group

Masatomi Akana

51 2017 Executive Officer

Yanhui Feng

46 2016 Executive Officer, General Manager of Subsidiaries

Yasunobu Kai

56 2018 Executive Officer, Chief Planning Officer of Oncology Business Group, Director of Planning of Oncology Business Group

Shohei Kanazawa

53 2017 Executive Officer, President of Consumer hhc Business Unit

Hiroyuki Kato

61 2018 Executive Officer, Chief Quality Officer

Yoshiteru Kato

58 2017 Executive Officer, President of Eisai Demand Chain Systems

Teiji Kimura

55 2016 Executive Officer, Chief Discovery Officer of Neurology Business Group

Hiroyuki Kobayashi

44 2017 Executive Officer, Chief Medical Officer of Japan & Asia, Chief Director of Medical

Lynn Kramer

67 2016 Executive Officer, Chief Clinical Officer of Neurology Business Group, Chief Medical Officer of Neurology Business Group

Masayuki Miyajima

56 2016 Executive Officer, President of Eisai Japan

Kazumasa Nagayama

38 2018 Executive Officer, Chief Strategy Officer, Director of Corporate Strategy

Akiko Nakahama

50 2018 Executive Officer, Manager of Medicine Development Center

Takashi Ohwa

55 2016 Executive Officer, Chief Medicine Creation Officer of Oncology Business Group, Chief Discovery Officer of Oncology Business Group

Shaji Procida

47 2014 Executive Officer, President of Subsidiary

Sayoko Sasaki

49 2018 Executive Officer, President of Asia & Latin America Region

Alexander Scott

53 2016 Executive Officer, Chief Strategy Officer in Neurology Business Group, Director of Strategy in Neurology Business Group

Mitsuaki Tanaka

56 2018 Executive Officer, Chief Planning Officer, Director of Corporate Planning

Hidenori Yabune

48 2017 Executive Officer, Chief Director of Regional Cooperation Metropolitan Area of Eisai Japan

Tatsuyuki Yasuno

50 2018 Executive Officer

Yasushi Okada

59 2017 Representative Executive Officer, Chief Talent Officer

Hirokazu Kanai

58 2016 Director

Noboru Naoe

62 2014 Director

Yutaka Tsuchiya

66 2017 Director

Bruce Aronson

66 2017 Independent Director

Shuzo Kaihori

70 2018 Independent Director

Tamaki Kakizaki

57 2016 Independent Director

Ryuichi Murata

70 2018 Independent Director

Daiken Tsunoda

52 2016 Independent Director

Hideyo Uchiyama

65 2018 Independent Director

Shinya Watanabe

2016 Director of Accounting in Main Finance & Accounting Unit